Similar articles

• Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.

  Kamisango K, Saiki I, Tanio Y, Kobayashi S, Fukuda T, Sekikawa I, Azuma I, Yamamura Y. Kamisango K, et al. Chem Pharm Bull (Tokyo). 1981 Jun;29(6):1644-54. doi: 10.1248/cpb.29.1644. Chem Pharm Bull (Tokyo). 1981. PMID: 7296716 No abstract available.
• Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine.

  Ishida H, Kitagawa M, Kiso M, Hasegawa A, Azuma I. Ishida H, et al. Carbohydr Res. 1990 Dec 15;208:267-72. doi: 10.1016/0008-6215(90)80109-g. Carbohydr Res. 1990. PMID: 2085813 No abstract available.
• Synthesis of immunologically active muramyl dipeptide derivatives containing a quinonyl moiety via aminoacyl intermediates.

  Fukuda T, Kobayashi S, Yukimasa H, Imada I, Fujino M, Azuma I, Yamamura Y. Fukuda T, et al. Chem Pharm Bull (Tokyo). 1981 Aug;29(8):2215-21. doi: 10.1248/cpb.29.2215. Chem Pharm Bull (Tokyo). 1981. PMID: 7318034 No abstract available.
• Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.

  Bahr GM. Bahr GM. J Antimicrob Chemother. 2003 Jan;51(1):5-8. doi: 10.1093/jac/dkg063. J Antimicrob Chemother. 2003. PMID: 12493780 Review. No abstract available.
• [Immunopharmacological activities of bacterial cell walls and related synthetic compounds (muramyl peptides)].

  Kotani S, Takada H. Kotani S, et al. Yakugaku Zasshi. 1983 Jan;103(1):1-27. doi: 10.1248/yakushi1947.103.1_1. Yakugaku Zasshi. 1983. PMID: 6191019 Review. Japanese. No abstract available.